Exploring Central Sensitization in Pregnant Women
In the Joints or in the Brain? Exploring Central Sensitization in Pregnant Women and Its Role in Pain, Physical Activity, Functioning and Health Following Pregnancy
1 other identifier
observational
144
1 country
1
Brief Summary
Pelvic Girdle Pain (PGP) is reported by 50% of pregnant women and up to 11 years after pregnancy, 10% of women have persistent and per definition chronic PGP. Central (nervous system) sensitization that elicits pain hypersensitivity, may be one explanation. The overall aim of this study is to explore features of central sensitization in pregnant women and its predictive ability on physical activity, functioning and health in women with PGP. Measurements of central sensitization will be done on two study groups, pregnant women with PGP and healthy controls. To identify women at risk to develop chronic pain in relation to a common pain experience ie PGP in pregnancy, may help us understand if central sensitization early in life explains why women develop chronic pain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 31, 2022
CompletedFirst Posted
Study publicly available on registry
August 19, 2022
CompletedStudy Start
First participant enrolled
August 15, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedApril 1, 2025
March 1, 2025
1.9 years
May 31, 2022
March 31, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
central sensitization measured by Patient Pain Drawing
spreading of pain
change from baseline (gestational week 20-30) at 6 weeks, at 6 months and at 12 months after delivery
central sensitization measured by conditioned pain modulation using an algometer and a occlusion cuff
Malfunctioning of descending nociceptive inhibitory pathways resulting in dysfunctional endogenous analgesia, assessed by a conditioned pain modulation (CPM)= 1. PressurePainThresholds (PPT)is assed by a digital algometer at symtomatic (sacrum and lumbar paravertebral muscles and 2 remote locations)+at asymptomatic regions(web thumb-index, prox 1/3 calf ) 2. mechanism of CPM will be induced by inflating an occlusion cuff (conditioning stimulus) at the participant's left arm to a painful intensity. The occlusion cuff is inflated until 'the first sensation of pain' is reported. This cuff inflation is maintained for 30 sec. The participant is than asked to rate the pain intensity, as a result of cuff inflation at the left arm, on a NRS (0=no pain-10=worst pain). Next, the cuff inflation is increased or decreased until pain intensity at the left arm was rated as 3/10 on NRS. The PPT assessments are then repeated during maintenance of the cuff inflation and relaxation of the left arm.
change from baseline (gestational week 20-30) at 6 weeks, at 6 months and at 12 months after delivery
Secondary Outcomes (8)
Pregnancy Physical Activity Questionnaire
change from baseline (gestational week 20-30) at 6 weeks, at 6 months and at 12 months after delivery
Pelvic Girdle Questionnaire
change from baseline (gestational week 20-30) at 6 weeks, at 6 months and at 12 months after delivery
Patients Specific Functioning Scale
change from baseline (gestational week 20-30) at 6 weeks, at 6 months and at 12 months after delivery
EuroQol 5-dimension questionnaire (EQ5D)
change from baseline (gestational week 20-30) at 6 weeks, at 6 months and at 12 months after delivery
Work Ability Index
change from baseline (gestational week 20-30),at 12 months after delivery,
- +3 more secondary outcomes
Other Outcomes (3)
Fear-Avoidance Beliefs Questionnaire subscale on physical activity (FABQ-PA)
change from baseline (gestational week 20-30) at 6 weeks, at 6 months and at 12 months after delivery
subscale Catastrophizing (CSQ-CAT),from the Coping Strategies Questionnaire
change from baseline (gestational week 20-30) at 6 weeks, at 6 months and at 12 months after delivery
General Self-Efficacy Scale
change from baseline (gestational week 20-30) at 6 weeks, at 6 months and at 12 months after delivery
Eligibility Criteria
pregnant women at maternity care units and social media
You may qualify if:
- pregnant (first time pregnant or previous experience of pregnancy)
- years of age or older
- have a single foetus pregnancy
- be in gestational weeks 20-30
- able to read and understand Swedish or English
You may not qualify if:
- no history of a fracture or malignant disease in the back, pelvis, pelvic floor or hips
- no systemic disease of the musculoskeletal or the nervous system
- no diseases such as gestational diabetes or diabetes type 1 and 2, hypertension
- no obstetric complications
- no contradiction for tests.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Göteborg Universitylead
- Vastra Gotaland Regioncollaborator
Study Sites (1)
Närhälsan Gibraltargatan
Gothenburg, 43654, Sweden
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Sonia Coelho Cristovao, PhD-student
CONTACT
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 31, 2022
First Posted
August 19, 2022
Study Start
August 15, 2023
Primary Completion
July 1, 2025
Study Completion
December 31, 2025
Last Updated
April 1, 2025
Record last verified: 2025-03